$AZRX: AzurRx BioPharma Receives Insititutional Review Board Approval to Commence its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis

Daily Insider Ratings Round Up 4/28/20 seekingalpha.com/article/434221…

@kailashnichani They just started clinical trials. Lots of different PT on $SRNE I’m now a bagholder of this clinicaltrials.gov/ct2/show/NCT04…

$CYDY $IBIO $VRUS $GOVX $CODX $NNVC $MRNA $GILD $AMRN $ACST #cytodyn #cydy #otcmarkets #news #borisjohnson #uk #coronavirus #covid19 #biotech #stocks #pennystocks insiderfinancial.com/uk-prime-minis…

Algernon Receives First Ethics Approval for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia pennystocks.com/penny-stock-ne… $AGN $AGNPF

Great news

Why does not its price move?

$ATBPF moving up, any news?

$PEN negative @RodBoydILM Penumbra Inc.’s Catheter Fail: Broken Tips and Lost Lives ffj-online.org/2020/09/14/pen…

UPDATE: Regulatory Moves Accelerated Planning For Citigroup CEO Michael Corbat's Retirement; Federal Reserve, OCC Likely To Require Citigroup To Develop Plan To Fix Risk Systems $C

Myovant relugolix data not 'fundamentally negative,' says JPMorgan The analyst added that the continues to view relugolix as a best-in-class GnRH modality, with "high potential" to become the leading ADT backbone therapy in the hormone-sensitive APC segment. $MYOV

$VIR files 300m shelf

image.investorsunderground.com/r2ka8y5gPy

FDA restricts use of $ICPT Ocaliva in PBC patients w/advanced cirrhosis last EPS call: 'We expect the final label will restrict to use in patients with decompensated cirrhosis, as well as in those patients with compensated cirrhosis, who have evidence of Portal hypertension.'

Disappointing tumor responses, more side effects, seen with latest Amgen KRAS combination studies statnews.com/2021/10/07/amg… $AMGN $MRTX

I just subscribed to Will’s Wall Street willmeade.substack.com/?utm_medium=we…

Edwin Dorsey Congrats brother! Great stuff from you Marc Cohodes Wolfpack Research The Friendly Bear & everyone else involved , sorry if I forgot names which I’m sure I did!